On the other hand, SIRT2 expression did not correlate with cognitive performance evaluated in a therapeutic trial targeted at amyloid precursor protein in Alzheimer’s disease [57]. This evidence concerns the gene SIRT2 and early-onset autosomal dominant Alzheimer disease.